Lumentum Holdings Inc. Q2 FY26 Earnings Analysis
Published 29 May 2026 | Communications Equipment | Market Cap: ₹67.0K Cr
Price
₹860.62
Market Cap
₹67.0K Cr
P/E Ratio
161.2
Revenue Rank
Margin Rank
Earnings Summary
- The company expects another quarterly revenue record in Q4 fiscal ’26, with guidance between $960 million and $1.01 billion, midpoint $985 million. - Q4 FY26 net revenue guidance: $960 million to $1.01 billion, midpoint $985 million, a new quarterly record.
📊 Revenue & Sales Performance
Rank 2- The company expects another quarterly revenue record in Q4 fiscal ’26, with guidance between $960 million and $1.01 billion, midpoint $985 million. - Components revenue saw a 20% sequential increase and 77% year-over-year growth; systems revenue increased 24% sequentially and 121% year-over-year. - EML shipments (laser chips) are on track for over 50% growth in units by December 2026 compared to December 2025. - Cloud transceiver shipments grew over 40% sequentially; ramp-up of 1.6T-speed transceivers is poised for fiscal Q4. - Ultra-high-power laser chip ramp for CPO applications progressing on schedule with significant purchase orders expected in H1 2027. - Scale-across components (pump lasers, narrow linewidth lasers) are growth levers and currently supply-constrained but ramping capacity is planned. - OCS growth is gated by supply, with long-term agreements ensuring sustained multi-year growth. - Inventory and CAPEX are being increased to support cloud and AI-related revenue growth.
📈 Profitability & Margins
Rank 1- Q4 FY26 net revenue guidance: $960 million to $1.01 billion, midpoint $985 million, a new quarterly record. - Projected Q4 non-GAAP operating margin: 35% to 36%, up from 32.2% in Q3. - Diluted net income per share for Q4 FY26 expected between $2.85 and $3.05, higher than Q3 non-GAAP EPS of $2.37. - Operating margin improved 2,140 basis points YoY in Q3, highlighting strong margin expansion potential. - Gross margin growth driven by better manufacturing utilization, favorable product mix, and pricing power. - Long-term agreements (LTAs) with customers expected to underpin CapEx and revenue growth. - Supply-demand imbalances, especially in lasers and transceivers, indicate sustained pricing power and margin improvement ahead. - Greensboro facility (online early 2028) adds over $5 billion incremental revenue potential in the long term.
🏗️ Capital Expenditure Plans
Yes- Acquisition of a fifth indium phosphide fab in Greensboro, North Carolina, announced in mid-March; plans to convert the facility from gallium arsenide to indium phosphide are underway. - Greensboro fab expected to start contributing incremental revenue in early 2028; represents significant capacity for years of future growth. - Significant capital expenditures planned to ramp pump laser capacity over the next 4 quarters at Rose Orchard facility in the U.S. to address supply constraints. - Active negotiations on long-term agreements (LTAs) with major customers involving potential prepayments, take-or-pay commitments, or price increases to help offset CapEx. - Shift towards contract manufacturing, which can improve margins and operational efficiency, is part of strategic investment in manufacturing base. - Ongoing investments and collaborations in ultra-high-power laser chip manufacturing for CPO applications, with multi-hundred million dollar purchase orders expected in H1 2027.
💰 Fundraising & Capital Structure
No information- The transcript does not mention any current or planned fundraising activities through debt or equity. - During Q3, cash and short-term investments increased by $2.02 billion, primarily due to NVIDIA’s direct investment in Lumentum. - There is no indication of new debt issuance or equity offerings discussed in the call. - The company is focusing on CapEx spending ($125 million in Q3) for manufacturing capacity to support growth but does not reference raising new capital to fund those investments. - Overall, no statements suggest upcoming fundraising via debt or equity in the near term.
📋 Order Book & Pipeline
Yes- The company references a significant backlog for the Optical Circuit Switches (OCS) business expected for 2027, describing it as their biggest area of focus with multiple substantial customer opportunities. - They are actively working on additional sizable wins in OCS, though it's too early to provide specifics or timing. - Transceiver demand outpaces supply, with a supply-demand imbalance greater than 30%, indicating considerable pending demand unmet due to supply constraints. - The company has ongoing discussions with major customers for increasing long-term agreements to secure demand, reflecting strong order visibility. - For pump lasers, there is higher than a 30% supply-demand imbalance; they are negotiating capacity expansions and long-term commitments with customers. - They expect a multihundred million-dollar purchase order for CPO laser chips in the first half of 2027. - Overall, the company is experiencing strong order intake across key segments but is supply constrained from fully fulfilling demand.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Lumentum Holdings Inc. Q2 FY26 results?
- The company expects another quarterly revenue record in Q4 fiscal ’26, with guidance between $960 million and $1.01 billion, midpoint $985 million. - Q4 FY26 net revenue guidance: $960 million to $1.01 billion, midpoint $985 million, a new quarterly record.
What is Lumentum Holdings Inc. share price analysis?
Lumentum Holdings Inc. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 161.2 with a market cap of $66,956. Investors should review the full earnings analysis for detailed insights.
Is Lumentum Holdings Inc. planning capital expenditure?
- Acquisition of a fifth indium phosphide fab in Greensboro, North Carolina, announced in mid-March; plans to convert the facility from gallium arsenide to indium phosphide are underway.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
